Cytosorbents Corporation (CTSO)
USD 1.0
(1.18%)
USD 1.0
(1.18%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.18 Million USD | 207.4% |
| 2022 | -3.89 Million USD | 89.84% |
| 2021 | -38.31 Million USD | 45.57% |
| 2020 | -70.39 Million USD | -1909.12% |
| 2019 | 3.89 Million USD | 131.31% |
| 2018 | -12.42 Million USD | -69.55% |
| 2017 | -7.32 Million USD | -2097.61% |
| 2016 | -333.53 Thousand USD | 93.73% |
| 2015 | -5.31 Million USD | -47.49% |
| 2014 | -3.6 Million USD | -569.24% |
| 2013 | -538.67 Thousand USD | 32.93% |
| 2012 | -803.11 Thousand USD | -30.36% |
| 2011 | -616.08 Thousand USD | -2936.59% |
| 2010 | 21.71 Thousand USD | 101.36% |
| 2009 | -1.59 Million USD | 40.89% |
| 2008 | -2.69 Million USD | -1175.54% |
| 2007 | -211.61 Thousand USD | 92.63% |
| 2006 | -2.87 Million USD | -5846.28% |
| 2005 | 50 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 9 Million USD | 115.27% |
| 2024 Q2 | 18.3 Million USD | 103.35% |
| 2023 FY | 4.18 Million USD | 207.4% |
| 2023 Q4 | 4.18 Million USD | -56.81% |
| 2023 Q3 | 9.68 Million USD | 95.13% |
| 2023 Q2 | 4.96 Million USD | 674.28% |
| 2023 Q1 | -864 Thousand USD | 77.81% |
| 2022 Q4 | -3.89 Million USD | 57.52% |
| 2022 Q1 | -29.36 Million USD | 23.37% |
| 2022 FY | -3.89 Million USD | 89.84% |
| 2022 Q2 | -16.65 Million USD | 43.28% |
| 2022 Q3 | -9.16 Million USD | 44.96% |
| 2021 Q1 | -67.54 Million USD | 4.05% |
| 2021 FY | -38.31 Million USD | 45.57% |
| 2021 Q2 | -52.34 Million USD | 22.5% |
| 2021 Q3 | -47.39 Million USD | 9.46% |
| 2021 Q4 | -38.31 Million USD | 19.15% |
| 2020 Q3 | -71.68 Million USD | -282.17% |
| 2020 FY | -70.39 Million USD | -1909.12% |
| 2020 Q1 | -10.33 Million USD | -365.54% |
| 2020 Q2 | -18.75 Million USD | -81.57% |
| 2020 Q4 | -70.39 Million USD | 1.8% |
| 2019 Q4 | 3.89 Million USD | 1779.48% |
| 2019 Q3 | 207 Thousand USD | 104.07% |
| 2019 Q2 | -5.08 Million USD | 38.87% |
| 2019 Q1 | -8.32 Million USD | 33.03% |
| 2019 FY | 3.89 Million USD | 131.31% |
| 2018 Q1 | -11.21 Million USD | -53.07% |
| 2018 Q3 | -14.99 Million USD | 2.57% |
| 2018 Q4 | -12.42 Million USD | 17.11% |
| 2018 FY | -12.42 Million USD | -69.55% |
| 2018 Q2 | -15.38 Million USD | -37.16% |
| 2017 Q4 | -7.32 Million USD | -34.89% |
| 2017 Q2 | -6.46 Million USD | -483.05% |
| 2017 FY | -7.32 Million USD | -2097.61% |
| 2017 Q1 | 1.68 Million USD | 605.77% |
| 2017 Q3 | -5.43 Million USD | 15.91% |
| 2016 Q4 | -333.53 Thousand USD | 77.44% |
| 2016 FY | -333.53 Thousand USD | 93.73% |
| 2016 Q3 | -1.47 Million USD | 60.98% |
| 2016 Q2 | -3.78 Million USD | -7.12% |
| 2016 Q1 | -3.53 Million USD | 33.47% |
| 2015 Q4 | -5.31 Million USD | 28.01% |
| 2015 FY | -5.31 Million USD | -47.49% |
| 2015 Q1 | -10.41 Million USD | -188.98% |
| 2015 Q2 | -8.01 Million USD | 23.05% |
| 2015 Q3 | -7.38 Million USD | 7.88% |
| 2014 Q3 | -433.42 Thousand USD | 89.6% |
| 2014 FY | -3.6 Million USD | -569.24% |
| 2014 Q4 | -3.6 Million USD | -731.82% |
| 2014 Q1 | -4.68 Million USD | -770.46% |
| 2014 Q2 | -4.16 Million USD | 11.09% |
| 2013 Q1 | -1.36 Million USD | -70.0% |
| 2013 FY | -538.67 Thousand USD | 32.93% |
| 2013 Q2 | -958.5 Thousand USD | 29.8% |
| 2013 Q3 | -788.41 Thousand USD | 17.75% |
| 2013 Q4 | -538.67 Thousand USD | 31.68% |
| 2012 FY | -803.11 Thousand USD | -30.36% |
| 2012 Q1 | -655.72 Thousand USD | -6.44% |
| 2012 Q4 | -803.11 Thousand USD | 26.17% |
| 2012 Q3 | -1.08 Million USD | -95.47% |
| 2012 Q2 | -556.48 Thousand USD | 15.13% |
| 2011 Q4 | -616.08 Thousand USD | 66.4% |
| 2011 Q1 | -1.94 Million USD | -9044.34% |
| 2011 Q2 | -2.88 Million USD | -48.77% |
| 2011 Q3 | -1.83 Million USD | 36.56% |
| 2011 FY | -616.08 Thousand USD | -2936.59% |
| 2010 Q3 | 113.46 Thousand USD | 126.82% |
| 2010 FY | 21.71 Thousand USD | 101.36% |
| 2010 Q4 | 21.71 Thousand USD | -80.86% |
| 2010 Q1 | -1.17 Million USD | 26.44% |
| 2010 Q2 | -423.02 Thousand USD | 63.96% |
| 2009 Q4 | -1.59 Million USD | -70.23% |
| 2009 FY | -1.59 Million USD | 40.89% |
| 2009 Q2 | -1.37 Million USD | 34.74% |
| 2009 Q3 | -937.31 Thousand USD | 31.76% |
| 2009 Q1 | -2.1 Million USD | 22.02% |
| 2008 Q1 | 53.23 Thousand USD | 125.16% |
| 2008 Q4 | -2.69 Million USD | 18.82% |
| 2008 Q3 | -3.32 Million USD | 6.17% |
| 2008 Q2 | -3.54 Million USD | -6757.18% |
| 2008 FY | -2.69 Million USD | -1175.54% |
| 2007 Q2 | -1.46 Million USD | 33.05% |
| 2007 Q1 | -2.18 Million USD | 23.79% |
| 2007 FY | -211.61 Thousand USD | 92.63% |
| 2007 Q4 | -211.61 Thousand USD | 72.68% |
| 2007 Q3 | -774.65 Thousand USD | 47.16% |
| 2006 Q4 | -2.87 Million USD | -11.5% |
| 2006 Q3 | -2.57 Million USD | 33.22% |
| 2006 Q2 | -3.85 Million USD | -5976.24% |
| 2006 FY | -2.87 Million USD | -5846.28% |
| 2006 Q1 | 65.66 Thousand USD | 6.05% |
| 2005 Q4 | 61.91 Thousand USD | 1006.67% |
| 2005 Q3 | 5595.00 USD | -88.81% |
| 2005 Q1 | 50 Thousand USD | 378.07% |
| 2005 FY | 50 Thousand USD | 0.0% |
| 2005 Q2 | 50 Thousand USD | 0.0% |
| 2004 Q4 | -17.98 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 84.558% |
| BrainsWay Ltd. | -10.32 Million USD | 140.523% |
| Cerus Corporation | 84.35 Million USD | 95.042% |
| Envoy Medical, Inc. | -3.81 Million USD | 209.649% |
| electroCore, Inc. | -9.95 Million USD | 142.009% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 181.6% |
| IceCure Medical Ltd | -9.93 Million USD | 142.098% |
| Inogen, Inc. | -103.56 Million USD | 104.038% |
| OrthoPediatrics Corp. | -9.26 Million USD | 145.128% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 214.859% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 131.931% |
| MaxCyte, Inc. | -27.76 Million USD | 115.063% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 181.392% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 826.338% |
| Orthofix Medical Inc. | 96.44 Million USD | 95.664% |
| PAVmed Inc | 29.08 Million USD | 85.622% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 124.689% |
| RxSight, Inc. | -6.68 Million USD | 162.605% |
| Sight Sciences, Inc. | -102.71 Million USD | 104.071% |
| SI-BONE, Inc. | 5.72 Million USD | 26.901% |
| TELA Bio, Inc. | -3.94 Million USD | 205.901% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 92.704% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -1088.072% |
| Acutus Medical, Inc. | 12.27 Million USD | 65.942% |
| Talis Biomedical Corporation | -57.06 Million USD | 107.329% |
| Spectral AI, Inc. | -3.5 Million USD | 219.452% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 108.708% |
| CVRx, Inc. | -59.95 Million USD | 106.975% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -110.772% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -227.324% |
| Bioventus Inc. | 372.51 Million USD | 98.877% |
| Venus Concept Inc. | 74.3 Million USD | 94.372% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 141.073% |
| LivaNova PLC | 62.53 Million USD | 93.312% |
| 908 Devices Inc. | -115.09 Million USD | 103.634% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 98.696% |
| Nemaura Medical Inc. | 9.92 Million USD | 57.864% |
| NeuroPace, Inc. | 54.33 Million USD | 92.304% |
| LENSAR, Inc. | -18.31 Million USD | 122.838% |
| Apyx Medical Corporation | -5.15 Million USD | 181.188% |
| Cutera, Inc. | 288.3 Million USD | 98.549% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 44.351% |
| BioSig Technologies, Inc. | 262 Thousand USD | -1496.189% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 109.541% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 145.462% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.702% |
| Axonics, Inc. | -77.19 Million USD | 105.418% |
| Outset Medical, Inc. | 67.67 Million USD | 93.821% |
| IRIDEX Corporation | -4.28 Million USD | 197.528% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 102.349% |
| IRadimed Corporation | -47.71 Million USD | 108.764% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 238.203% |
| INVO Bioscience, Inc. | 8.45 Million USD | 50.515% |
| Telesis Bio, Inc. | 32.63 Million USD | 87.185% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 267.138% |
| Varex Imaging Corporation | 316.9 Million USD | 98.68% |
| Quipt Home Medical Corp. | 81.73 Million USD | 94.883% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 250.324% |
| Pulmonx Corporation | -42.36 Million USD | 109.873% |
| Dynatronics Corporation | 6.2 Million USD | 32.592% |
| Modular Medical, Inc. | -8.04 Million USD | 152.002% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 197.324% |
| Semler Scientific, Inc. | -57.13 Million USD | 107.32% |
| InMode Ltd. | -135.39 Million USD | 103.089% |
| Bruker Corporation | 891.3 Million USD | 99.531% |
| DexCom, Inc. | 2.02 Billion USD | 99.794% |
| Align Technology, Inc. | -840.47 Million USD | 100.498% |
| Viveve Medical, Inc. | -13.81 Million USD | 130.276% |
| ZimVie Inc. | 450.41 Million USD | 99.072% |
| Movano Inc. | -5.86 Million USD | 171.292% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 103.11% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 826.338% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -110.772% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 98.828% |
| Profound Medical Corp. | -18.17 Million USD | 123.005% |
| Insulet Corporation | 798.1 Million USD | 99.476% |
| enVVeno Medical Corporation | -2.21 Million USD | 288.549% |
| Surmodics, Inc. | -12.01 Million USD | 134.81% |
| iCAD, Inc. | -21.2 Million USD | 119.718% |
| Nuwellis, Inc. | -2.81 Million USD | 248.351% |
| Biotricity, Inc. | 23.09 Million USD | 81.89% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 95.534% |
| Aethlon Medical, Inc. | -4.5 Million USD | 192.899% |
| InspireMD, Inc. | -8.04 Million USD | 151.983% |
| PAVmed Inc. | 29.08 Million USD | 85.622% |
| BIOLASE, Inc. | 11.34 Million USD | 63.135% |
| Beyond Air, Inc. | 6.22 Million USD | 32.862% |
| FONAR Corporation | -14.66 Million USD | 128.516% |
| AxoGen, Inc. | 32.26 Million USD | 87.039% |
| Vivani Medical, Inc. | 42 Thousand USD | -9857.179% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 139.238% |
| Inari Medical, Inc. | -7.16 Million USD | 158.4% |
| UFP Technologies, Inc. | 40.77 Million USD | 89.743% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -36.283% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 187.649% |
| Tenon Medical, Inc. | -1.25 Million USD | 433.228% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 154.983% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 135.065% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.811% |
| Sintx Technologies, Inc. | 905 Thousand USD | -362.101% |
| NanoVibronix, Inc. | -3.27 Million USD | 227.578% |
| Quanterix Corporation | -132.95 Million USD | 103.145% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 250.324% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 118.699% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 99.445% |
| TransMedics Group, Inc. | 121.13 Million USD | 96.548% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 115.974% |
| NeuroMetrix, Inc. | -1.49 Million USD | 380.471% |
| Hyperfine, Inc. | -75.61 Million USD | 105.53% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 97.252% |
| Biomerica, Inc. | -3.38 Million USD | 223.545% |
| Bone Biologics Corporation | -3.02 Million USD | 238.177% |
| AVITA Medical, Inc. | -26.23 Million USD | 115.943% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 327.48% |
| Silk Road Medical, Inc | 64.42 Million USD | 93.509% |